R
RejuvenAir
CSA Medical is a provider of innovative spray cryotherapy medical device solutions
About RejuvenAir
CSA Medical is a pioneering medical technology company specializing in cryotherapy solutions for patients suffering from chronic obstructive pulmonary disease (COPD) with chronic bronchitis. Operating primarily in the European market, CSA Medical's flagship product, the RejuvenAir System, has been approved for use in Europe following a successful multi-center clinical trial. This innovative system utilizes metered cryospray technology to deliver liquid nitrogen at -196°C to targeted areas within the lungs, effectively freezing damaged cells and promoting a rejuvenative healing process. The treatment is minimally invasive, performed via a bronchoscopic procedure, and has shown significant improvements in patient-reported quality of life for up to 12 months post-treatment. CSA Medical's business model focuses on the development and commercialization of advanced medical devices, generating revenue through the sale and licensing of its proprietary technologies. The company serves healthcare providers and patients in the respiratory care market, aiming to address unmet medical needs with cutting-edge solutions.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 33
- Open positions
- None listed
- Dealroom signal
- 76.1/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotechnology, Chronic Disease, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2B, B2C
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES DOther financing | Sep 2024 | $53M | $212M | First Analysis · Blue Heron Capital · Ascension Ventures · Yonjin Venture | ↗ |
| DEBTDebt | Feb 2019 | $5.1M | — | Undisclosed | — |
Growth signals
Latest recorded traffic for RejuvenAir is 460 monthly website visits, down 75.8% over the last three months. RejuvenAir's team grew 6.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
RejuvenAir in the Lexington ecosystem
The RejuvenAir office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
Rose Park Advisors
Heron Capital
SV Health Investors
First Analysis
Intersouth Partners
Series B and later7 investors entered at this stage
Ascension
Guide Ventures
Horizon Technology Finance Corporation
Yonjin Venture
TVM Capital Life Science
Blue Heron Capital
Ascension Ventures
Other known investors1 additional known investor
Walter Reed National Military Medical Center
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about RejuvenAir on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See RejuvenAir’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









